These results, along with a preceding report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the idea of targeting ACKR3 as a unique way to modulate the opioid method, which could open new therapeutic avenues for opioid-similar Conditions. It will also be lawfully marketed https://seingalo470wvr1.wiki-racconti.com/user